دورية أكاديمية
أعرض في EDS

Training stem cells for treatment of malignant brain tumors.

التفاصيل البيبلوغرافية
العنوان: Training stem cells for treatment of malignant brain tumors.
المؤلفون: Li SC; Shengwen Calvin Li, Mustafa H Kabeer, Long T Vu, Vic Keschrumrus, Brent A Dethlefs, William G Loudon, Neuro-Oncology and Stem Cell Research Laboratory, Center for Neuroscience Research, Children's Hospital of Orange County, University of California-Irvine, Orange, CA 92868, United States., Kabeer MH; Shengwen Calvin Li, Mustafa H Kabeer, Long T Vu, Vic Keschrumrus, Brent A Dethlefs, William G Loudon, Neuro-Oncology and Stem Cell Research Laboratory, Center for Neuroscience Research, Children's Hospital of Orange County, University of California-Irvine, Orange, CA 92868, United States., Vu LT; Shengwen Calvin Li, Mustafa H Kabeer, Long T Vu, Vic Keschrumrus, Brent A Dethlefs, William G Loudon, Neuro-Oncology and Stem Cell Research Laboratory, Center for Neuroscience Research, Children's Hospital of Orange County, University of California-Irvine, Orange, CA 92868, United States., Keschrumrus V; Shengwen Calvin Li, Mustafa H Kabeer, Long T Vu, Vic Keschrumrus, Brent A Dethlefs, William G Loudon, Neuro-Oncology and Stem Cell Research Laboratory, Center for Neuroscience Research, Children's Hospital of Orange County, University of California-Irvine, Orange, CA 92868, United States., Yin HZ; Shengwen Calvin Li, Mustafa H Kabeer, Long T Vu, Vic Keschrumrus, Brent A Dethlefs, William G Loudon, Neuro-Oncology and Stem Cell Research Laboratory, Center for Neuroscience Research, Children's Hospital of Orange County, University of California-Irvine, Orange, CA 92868, United States., Dethlefs BA; Shengwen Calvin Li, Mustafa H Kabeer, Long T Vu, Vic Keschrumrus, Brent A Dethlefs, William G Loudon, Neuro-Oncology and Stem Cell Research Laboratory, Center for Neuroscience Research, Children's Hospital of Orange County, University of California-Irvine, Orange, CA 92868, United States., Zhong JF; Shengwen Calvin Li, Mustafa H Kabeer, Long T Vu, Vic Keschrumrus, Brent A Dethlefs, William G Loudon, Neuro-Oncology and Stem Cell Research Laboratory, Center for Neuroscience Research, Children's Hospital of Orange County, University of California-Irvine, Orange, CA 92868, United States., Weiss JH; Shengwen Calvin Li, Mustafa H Kabeer, Long T Vu, Vic Keschrumrus, Brent A Dethlefs, William G Loudon, Neuro-Oncology and Stem Cell Research Laboratory, Center for Neuroscience Research, Children's Hospital of Orange County, University of California-Irvine, Orange, CA 92868, United States., Loudon WG; Shengwen Calvin Li, Mustafa H Kabeer, Long T Vu, Vic Keschrumrus, Brent A Dethlefs, William G Loudon, Neuro-Oncology and Stem Cell Research Laboratory, Center for Neuroscience Research, Children's Hospital of Orange County, University of California-Irvine, Orange, CA 92868, United States.
المصدر: World journal of stem cells [World J Stem Cells] 2014 Sep 26; Vol. 6 (4), pp. 432-40.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Baishideng Publishing Group Country of Publication: United States NLM ID: 101535826 Publication Model: Print Cited Medium: Print ISSN: 1948-0210 (Print) Linking ISSN: 19480210 NLM ISO Abbreviation: World J Stem Cells Subsets: PubMed not MEDLINE
أسماء مطبوعة: Publication: 2014- : Pleasanton, CA : Baishideng Publishing Group
Original Publication: Beijing, China : Beijing Baishideng BioMed Scientifc Company
مستخلص: The treatment of malignant brain tumors remains a challenge. Stem cell technology has been applied in the treatment of brain tumors largely because of the ability of some stem cells to infiltrate into regions within the brain where tumor cells migrate as shown in preclinical studies. However, not all of these efforts can translate in the effective treatment that improves the quality of life for patients. Here, we perform a literature review to identify the problems in the field. Given the lack of efficacy of most stem cell-based agents used in the treatment of malignant brain tumors, we found that stem cell distribution (i.e., only a fraction of stem cells applied capable of targeting tumors) are among the limiting factors. We provide guidelines for potential improvements in stem cell distribution. Specifically, we use an engineered tissue graft platform that replicates the in vivo microenvironment, and provide our data to validate that this culture platform is viable for producing stem cells that have better stem cell distribution than with the Petri dish culture system.
References: Nat Rev Neurosci. 2006 Jan;7(1):75-84. (PMID: 16371952)
Nat Genet. 2013 Aug;45(8):927-32. (PMID: 23817572)
Cancer Cell. 2012 Oct 16;22(4):425-37. (PMID: 23079654)
Expert Rev Anticancer Ther. 2007 Dec;7(12 Suppl):S45-50. (PMID: 18076318)
Clin Neurosurg. 2006;53:336-44. (PMID: 17380772)
J Neurooncol. 2007 Dec;85(3):329-38. (PMID: 17581698)
Nature. 2012 Aug 23;488(7412):522-6. (PMID: 22854781)
Cancer Cell Int. 2008 May 22;8:9. (PMID: 18498656)
Expert Rev Anticancer Ther. 2007 Dec;7(12 Suppl):S69-77. (PMID: 18076312)
J Neurooncol. 2007 Jul;83(3):241-7. (PMID: 17570034)
Sci Transl Med. 2012 Dec 12;4(164):164ps25. (PMID: 23241742)
Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12846-51. (PMID: 11070094)
Curr Stem Cell Res Ther. 2012 Jan;7(1):2-14. (PMID: 21466480)
Biochim Biophys Acta. 2011 Dec;1816(2):191-8. (PMID: 21767610)
Nat Genet. 2013 Jun;45(6):602-12. (PMID: 23583981)
Cancer Cell. 2010 Jan 19;17(1):98-110. (PMID: 20129251)
Proc Natl Acad Sci U S A. 2011 Aug 2;108(31):12793-8. (PMID: 21768375)
Neurosurg Clin N Am. 2007 Jan;18(1):71-80, ix. (PMID: 17244555)
Pediatr Blood Cancer. 2008 Feb;50(2):337-40. (PMID: 17458873)
N Engl J Med. 2012 Mar 8;366(10):883-892. (PMID: 22397650)
Nat Med. 2007 Apr;13(4):439-47. (PMID: 17351625)
Cancer Cell Int. 2007 Jun 04;7:9. (PMID: 17547749)
Pediatr Neurosurg. 2001 Oct;35(4):173-80. (PMID: 11694794)
Cell Biol Int. 2009 Mar;33(3):255-67. (PMID: 19084605)
Brain Inj. 2012;26(7-8):950-61. (PMID: 22630044)
Sci Transl Med. 2013 May 8;5(184):184ra59. (PMID: 23658244)
Stem Cell Rev. 2008 Spring;4(1):3-11. (PMID: 18286392)
J Neurooncol. 2008 Feb;86(3):337-47. (PMID: 17906911)
Future Oncol. 2014 Feb;10(3):401-15. (PMID: 24559447)
Cancer Res. 2002 Jul 1;62(13):3603-8. (PMID: 12097260)
Nat Biotechnol. 2014 Jul;32(7):644-52. (PMID: 24952901)
J Clin Oncol. 2004 Mar 15;22(6):999-1006. (PMID: 15020603)
Cell. 2006 Aug 25;126(4):677-89. (PMID: 16923388)
Pediatr Blood Cancer. 2007 Sep;49(3):298-305. (PMID: 16779805)
Stem Cells. 2008 Mar;26(3):831-41. (PMID: 18192232)
Pediatr Hematol Oncol. 2003 Mar;20(2):89-101. (PMID: 12554520)
Nat Biotechnol. 2014 Aug;32(8):760-72. (PMID: 25093883)
Cancer Res. 2007 Jan 1;67(1):22-5. (PMID: 17210679)
J Neurooncol. 1999 Jan;41(1):47-53. (PMID: 10222422)
Science. 2014 Aug 22;345(6199):1247391. (PMID: 25146295)
Curr Stem Cell Res Ther. 2010 Dec;5(4):297-3. (PMID: 20528752)
Nat Med. 2000 Apr;6(4):447-50. (PMID: 10742153)
J Natl Cancer Inst. 2013 Jul 3;105(13):968-77. (PMID: 23821758)
N Engl J Med. 2008 Jan 3;358(1):18-27. (PMID: 18172171)
Nat Genet. 2013 Oct;45(10):1113-20. (PMID: 24071849)
N Engl J Med. 2007 Nov 1;357(18):1821-8. (PMID: 17978290)
J Neurooncol. 2007 Jan;81(1):61-5. (PMID: 16773215)
Stem Cell Rev Rep. 2010 Jun;6(2):317-33. (PMID: 20237964)
J Neurosci. 2005 Mar 9;25(10):2637-46. (PMID: 15758174)
Annu Rev Pathol. 2006;1:97-117. (PMID: 18039109)
Stem Cells Dev. 2012 Mar 1;21(4):503-6. (PMID: 21933025)
Science. 2014 Jan 10;343(6167):189-193. (PMID: 24336570)
Curr Stem Cell Res Ther. 2007 Jan;2(1):89-103. (PMID: 18220894)
Curr Stem Cell Res Ther. 2007 Jan;2(1):53-63. (PMID: 18240454)
معلومات مُعتمدة: R01 CA164509 United States CA NCI NIH HHS
فهرسة مساهمة: Keywords: Engineered tissue graft; Malignant brain tumors; Organotypic slice model; Stem cells
تواريخ الأحداث: Date Created: 20140927 Date Completed: 20140926 Latest Revision: 20211021
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC4172671
DOI: 10.4252/wjsc.v6.i4.432
PMID: 25258664
قاعدة البيانات: MEDLINE
الوصف
تدمد:1948-0210
DOI:10.4252/wjsc.v6.i4.432